The Crystal Structure of Orthocetamol Solved by 3D Electron Diffraction

  • Angew Chem Int Ed Engl. 2019 Aug 5;58(32):10919-10922. doi: 10.1002/anie.201904564.
Iryna Andrusenko  1 Victoria Hamilton  2  3 Enrico Mugnaioli  1 Arianna Lanza  1 Charlie Hall  2  4 Jason Potticary  2 Simon R Hall  2 Mauro Gemmi  1
Affiliations
  • 1. Center for Nanotechnology Innovation@NEST, Istituto Italiano di Tecnologia, Piazza San Silvestro 12, Pisa, Italy.
  • 2. Complex Functional Materials Group, School of Chemistry, University of Bristol, Bristol, BS8 1TS, UK.
  • 3. Bristol Centre for Functional Nanomaterials, Centre for Nanoscience and Quantum Information, Tyndall Avenue, Bristol, BS8 1FD, UK.
  • 4. Centre for Doctoral Training in Condensed Matter Physics, HH Wills Physics Laboratory, Tyndall Avenue, Bristol, BS8 1TL, UK.
Abstract

Orthocetamol is a regioisomer of the well-known pain medication paracetamol and a promising analgesic and an anti-arthritic medicament itself. However, orthocetamol cannot be grown as single crystals suitable for X-ray diffraction, so its crystal structure has remained a mystery for more than a century. Here, we report the ab-initio structure determination of orthocetamol obtained by 3D electron diffraction, combining a low-dose acquisition method and a dedicated single-electron detector for recording the diffracted intensities. The structure is monoclinic, with a pseudo-tetragonal cell that favors multiple twinning on a scale of a few tens of nanometers. The successful application of 3D electron diffraction to orthocetamol introduces a new gold standard of total structure solution in all cases where X-ray diffraction and electron-microscope imaging methods fail.

Keywords
3D electron diffraction; nanomaterials; pharmaceutical compound; structure determination; twinning.